HypoglycemiaTreatment of Type 1 Diabetes

Nasal Glucagon Treatment Succeeds in Trials

According to a T1D Exchange article, researchers presented positive results in clinical trials of a new glucagon nasal powder at the Advanced Technologies & Treatments Diabetes conference in Paris, France.

Locemia Solutions is developing the new treatment option, dubbed for now simply as Glucagon Nasal Powder. The powder proved equally as effective as injectable glucagon in recent preliminary clinical trials. The company partnered with T1D Exchange, which conducted an online survey to determine injectable glucagon use among the organization’s Glu community. That data was taken to the FDA, which approved clinical trials.

The new treatment helps combat hypoglycemia in emergency situations. Because the solution is taken through the nose, it is much simpler to administer than glucagon kits on the market, which have to be properly measured and mixed with water and then injected into the patient. The current system of administering glucagon has proven daunting for any inexperienced, non-medical professional. In such situations, many people dial 911 rather than administer the glucagon, a move that can delay needed treatment and drive up medical costs.

User-friendly glucagon is considered a key component in the development of a truly closed-loop artificial pancreas system, with some researchers working on developing a two-hormone pump system of insulin and glucagon to combat hyperglycemia and hypoglycemia. Xeris Pharmaceuticals has been working on creating a form of liquid glucagon that is stable at room temperature and which can be used in pumps and pens.

Thanks for reading this Insulin Nation article. Want more Type 1 news? Subscribe here.

Have Type 2 diabetes or know someone who does? Try Type 2 Nation, our sister publication.

Travis served as a staff writer for Insulin Nation and Type 2 Nation in 2015. Previously, he was a staff writer for Insight, a high school newspaper, as well as a copywriter for The Emersonian, Emerson's yearbook.

Related Articles

41 Comments

  1. “excellent issues altogether, you just won a logo new reader. What might you recommend about your publish that you just made some days ago? Any certain?”

  2. xceudbaxxoa,A fascinating discussion is definitely worth comment. I do think that you ought to publish more on this topic, it may not be a taboo oghohrscz,subject but generally folks don’t talk about such subjects. To the next! All the best!!

  3. 901649 733392When I originally commented I clicked the -Notify me when new feedback are added- checkbox and now every time a remark is added I get four emails with the same comment. Is there any approach you will be able to remove me from that service? Thanks! 421253

  4. bctvoxhdwar,Very informative useful, infect very precise and to the point. Im a student a Business Education and surfing things on Google and found your website and found it very informative.

  5. zmsebh,A fascinating discussion is definitely worth comment. I do think that you ought to publish more on this topic, it may not be a taboo lhewzdjuaby,subject but generally folks don’t talk about such subjects. To the next! All the best!!

  6. Aw, this was an extremely good post. Spending some time and
    actual effort to generate a really good article… but what can I say… I put things off a lot and don’t manage to get nearly anything done.

  7. fkdwjoi,We have a team of experts who could get you the correct settings for Bellsouth net email login through which, you can easily configure your email account with MS Outlook.

  8. Regulators accused the automakers of colluding at their annual “five-person team” technical meeting. BMW, Daimler, Volkswagen and its subsidiaries Audi and Porsche attended the meeting. The European Commission said that the technology affected by the plan should have reduced harmful nitrogen oxides emitted by diesel vehicles.

Leave a Reply

Your email address will not be published.

Back to top button